Fertility medications and the risk of cancer

References

• ACOG Committee Opinion. Primary and preventive care: periodic assessments. No. 483. Obstet. Gynecol. 117, 1008–1015 (2011).
   PubMedGoogle Scholar
• Eheman C, Henley SJ, Ballard-Barbash R et al. Annual Report to the Nation on the status of cancer, 1975–2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer 118(9), 2338–2366 (2012).
   PubMed Web of Science ®Google Scholar
• Hanna L, Adams M. Prevention of ovarian cancer. Best Pract. Res. Clin. Obstet. Gynaecol. 20(2), 339–362 (2006).
   PubMed Web of Science ®Google Scholar
• Schorge JO, Modesitt SC, Coleman RL et al. SGO White Paper on ovarian cancer: etiology, screening and surveillance. Gynecol. Oncol. 119(1), 7–17 (2010).
   PubMed Web of Science ®Google Scholar
• Iodice S, Barile M, Rotmensz N et al. Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis. Eur. J. Cancer 46(12), 2275–2284 (2010).
   PubMed Web of Science ®Google Scholar
• Collaborative Group on Epidemiological Studies on Ovarian Cancer; Beral V, Doll R, Hermon C et al. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 371, 303–314 (2008).
   PubMed Web of Science ®Google Scholar
• Sueblinvong T, Carney ME. Current understanding of risk factors for ovarian cancer. Curr. Treat Opt. Oncol. 10, 67–81 (2009).
   PubMed Web of Science ®Google Scholar
• Kokcu A. Relationship between endometriosis and cancer from current perspective. Arch. Gynecol. Obstet. 284(6), 1473–1479 (2011).
   PubMed Web of Science ®Google Scholar
• Munksgaard PS, Blaakaer J. The association between endometriosis and gynecological cancers and breast cancer: a review of epidemiological data. Gynecol. Oncol. 123(1), 157–163 (2011).
   PubMed Web of Science ®Google Scholar
• Dietl J, Wischhusen J, Häusler SF. The post-reproductive Fallopian tube: better removed? Hum. Reprod. 26(11), 2918–2924 (2011).
   PubMed Web of Science ®Google Scholar
• Bolton KL, Ganda C, Berchuck A, Pharaoh PD, Gayther SA. Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the Ovarian Cancer Association Consortium (OCAC). J. Intern. Med. 271(4), 366–378 (2012).
   PubMed Web of Science ®Google Scholar
• Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN. Proportion of breast cancer cases in the United States explained by well-established risk factors. J. Natl Cancer Inst. 87(22), 1681–1685 (1995).
   PubMed Web of Science ®Google Scholar
• Jabbour HN, Kelly RW, Fraser HM, Critchley HO. Endocrine regulation of menstruation. Endocr. Rev. 27(1), 17–46 (2006).
   PubMed Web of Science ®Google Scholar
• Chittenden BG, Fullerton G, Maheshwari A, Bhattacharya S. Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reprod. Biomed. Online 19(3), 398–405 (2009).
   PubMed Web of Science ®Google Scholar
• Chlebowski RT, Anderson GL. Changing concepts: menopausal hormone therapy and breast cancer. J. Natl Cancer Inst. 104(7), 517–527 (2012).
   PubMed Web of Science ®Google Scholar
• Cramer DW. The epidemiology of endometrial and ovarian cancer. Hematol. Oncol. Clin. North Am. 26(1), 1–12 (2012).
   PubMed Web of Science ®Google Scholar
• Leitzmann MF, Koebnick C, Danforth KN et al. Body mass index and risk of ovarian cancer. Cancer 115(4), 812–822 (2009).
   PubMed Web of Science ®Google Scholar
• Goldberg GL, Runowicz CD. Ovarian carcinoma of low malignant potential, infertility, and induction of ovulation – is there a link? Am. J. Obstet. Gynecol. 166(3), 853–854 (1992).
   PubMed Web of Science ®Google Scholar
• Dietl J. Ovulation and ovarian cancer. Lancet 338(8764), 445 (1991).
   PubMedGoogle Scholar
• Modan B, Ron E, Lerner-Geva L et al. Cancer incidence in a cohort of infertile women. Am. J. Epidemiol. 147(11), 1038–1042 (1998).
   PubMed Web of Science ®Google Scholar
• Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am. J. Epidemiol. 136(10), 1184–1203 (1992).
   PubMed Web of Science ®Google Scholar
• Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N. Engl. J. Med. 331(12), 771–776 (1994).
   PubMed Web of Science ®Google Scholar
• Rossing MA, Tang MT, Flagg EW, Weiss LK, Wicklund KG. A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs. Am. J. Epidemiol. 160(11), 1070–1078 (2004).
   PubMed Web of Science ®Google Scholar
• Parazzini F, Negri E, La Vecchia C, Moroni S, Franceschi S, Crosignani PG. Treatment for infertility and risk of invasive epithelial ovarian cancer. Hum. Reprod. 12(10), 2159–2161 (1997).
   PubMed Web of Science ®Google Scholar
• Potashnik G, Lerner-Geva L, Genkin L, Chetrit A, Lunenfeld E, Porath A. Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. Fertil. Steril. 71(5), 853–859 (1999).
   PubMed Web of Science ®Google Scholar
• Venn A, Watson L, Lumley J, Giles G, King C, Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 346(8981), 995–1000 (1995).
   PubMed Web of Science ®Google Scholar
• Venn A, Watson L, Bruinsma F, Giles G, Healy D. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 354(9190), 1586–1590 (1999).
   PubMed Web of Science ®Google Scholar
• Dor J, Lerner-Geva L, Rabinovici J et al. Cancer incidence in a cohort of infertile women who underwent in vitro fertilization. Fertil. Steril. 77(2), 324–327 (2002).
   PubMed Web of Science ®Google Scholar
• Brinton LA, Lamb EJ, Moghissi KS et al. Ovarian cancer risk after the use of ovulation-stimulating drugs. Obstet. Gynecol. 103(6), 1194–1203 (2004).
   PubMed Web of Science ®Google Scholar
• Sanner K, Conner P, Bergfeldt K et al. Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden. Fertil. Steril. 91(4), 1152–1158 (2009).
   PubMed Web of Science ®Google Scholar
• Källén B, Finnström O, Lindam A, Nilsson E, Nygren KG, Olausson PO. Malignancies among women who gave birth after in vitro fertilization. Hum. Reprod. 26(1), 253–258 (2011).
   PubMed Web of Science ®Google Scholar
• Ness RB, Cramer DW, Goodman MT et al. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am. J. Epidemiol. 155(3), 217–224 (2002).
   PubMed Web of Science ®Google Scholar
• Parazzini F, Negri E, La Vecchia C et al. Treatment for fertility and risk of ovarian tumors of borderline malignancy. Gynecol. Oncol. 68(3), 226–228 (1998).
   PubMed Web of Science ®Google Scholar
• van Leeuwen FE, Klip H, Mooij TM et al. Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort. Hum. Reprod. 26(12), 3456–3465 (2011).
   PubMed Web of Science ®Google Scholar
• Shuen AY, Foulkes WD. Inherited mutations in breast cancer genes–risk and response. J. Mammary Gland Biol. Neoplasia 16(1), 3–15 (2011).
   PubMed Web of Science ®Google Scholar
• Lerner-Geva L, Keinan-Boker L, Blumstein T et al. Infertility, ovulation induction treatments and the incidence of breast cancer – a historical prospective cohort of Israeli women. Breast Cancer Res. Treat. 100(2), 201–212 (2006).
   PubMed Web of Science ®Google Scholar
• Gauthier E, Paoletti X, Clavel-Chapelon F; E3N group. Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study. Hum. Reprod. 19(10), 2216–2221 (2004).
   PubMed Web of Science ®Google Scholar
• Brinton LA, Scoccia B, Moghissi KS et al. Breast cancer risk associated with ovulation-stimulating drugs. Hum. Reprod. 19(9), 2005–2013 (2004).
   PubMed Web of Science ®Google Scholar
• Calderon-Margalit R, Friedlander Y, Yanetz R et al. Cancer risk after exposure to treatments for ovulation induction. Am. J. Epidemiol. 169(3), 365–375 (2009).
   PubMed Web of Science ®Google Scholar
• Burkman RT, Tang MT, Malone KE et al. Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women’s Contraceptive and Reproductive Experiences Study. Fertil. Steril. 79(4), 844–851 (2003).
   PubMed Web of Science ®Google Scholar
• Stewart LM, Holman CD, Hart R, Bulsara MK, Preen DB, Finn JC. in vitro fertilization and breast cancer: is there cause for concern? Fertil. Steril. 98(2), 334–340 (2012).
   PubMed Web of Science ®Google Scholar
• Kotsopoulos J, Librach CL, Lubinski J et al.; Hereditary Breast Cancer Clinical Study Group. Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case–control study. Cancer Causes Control 19(10), 1111–1119 (2008).
   PubMed Web of Science ®Google Scholar
• Zreik TG, Mazloom A, Chen Y et al. Fertility drugs and the risk of breast cancer: a meta-analysis and review. Breast Cancer Res. Treat. 124(1), 13–26 (2010).
   PubMed Web of Science ®Google Scholar
• Jensen A, Sharif H, Kjaer SK. Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study. Am. J. Epidemiol. 170(11), 1408–1414 (2009).
   PubMed Web of Science ®Google Scholar
• Hannibal CG, Jensen A, Sharif H, Kjaer SK. Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study. Hum. Reprod. 23(2), 451–456 (2008).
   PubMed Web of Science ®Google Scholar
• Kanakas N, Mantzavinos T. Fertility drugs and gynecologic cancers. Ann NY Acad Sci. 1092, 256–278 (2006).
   Google Scholar
• Cetin I, Cozzi V, Antonazzo P. Infertility as a cancer risk factor – a review. Placenta 229, S169–S177 (2008).
   Google Scholar
• Althuis MD, Scoccia B, Lamb EJ et al. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs. Am. J. Obstet. Gynecol. 193(3 Pt 1), 668–674 (2005).
   PubMed Web of Science ®Google Scholar
• Hannibal CG, Jensen A, Sharif H, Kjaer SK. Malignant melanoma risk after exposure to fertility drugs: results from a large Danish cohort study. Cancer Causes Control 19(7), 759–765 (2008).
   PubMed Web of Science ®Google Scholar
• Siegel R, DeSantis C, Virgo K et al. Cancer treatment and survivorship statistics, 2012. CA. Cancer J. Clin. 62(4), 220–241 (2012).
   PubMed Web of Science ®Google Scholar
• Oktem O, Oktay K. Fertility preservation for breast cancer patients. Semin. Reprod. Med. 27(6), 486–492 (2009).
   PubMed Web of Science ®Google Scholar
• Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J. Clin. Oncol. 23(19), 4347–4353 (2005).
   PubMed Web of Science ®Google Scholar
• Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J. Clin. Oncol. 26(16), 2630–2635 (2008).
   PubMed Web of Science ®Google Scholar
• Ayhan A, Celik H, Taskiran C, Bozdag G, Aksu T. Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer. Eur. J. Gynaecol. Oncol. 24(3–4), 223–232 (2003).
   PubMed Web of Science ®Google Scholar
• Marcickiewicz J, Brännström M. Fertility preserving surgical treatment of borderline ovarian tumour: long-term consequence for fertility and recurrence. Acta Obstet. Gynecol. Scand. 85(12), 1496–1500 (2006).
   PubMed Web of Science ®Google Scholar
• Ayhan A, Salman MC, Celik H, Dursun P, Ozyuncu O, Gultekin M. Association between fertility drugs and gynecologic cancers, breast cancer, and childhood cancers. Acta Obstet. Gynecol. Scand. 83(12), 1104–1111 (2004).
   PubMed Web of Science ®Google Scholar
• Brinton LA, Krüger Kjaer S, Thomsen BL et al. Childhood tumor risk after treatment with ovulation-stimulating drugs. Fertil. Steril. 81(4), 1083–1091 (2004).
   PubMed Web of Science ®Google Scholar
• Källén B, Finnström O, Nygren KG, Olausson PO. In vitro fertilization in Sweden: child morbidity including cancer risk. Fertil. Steril. 84(3), 605–610 (2005).
   PubMed Web of Science ®Google Scholar
• Kovács P, Mátyás S, Ungár L. Preservation of fertility in reproductive-age women with the diagnosis of cancer. Eur. J. Gynaecol. Oncol. 29(5), 425–434 (2008).
   PubMed Web of Science ®Google Scholar